Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C H Fearon

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|July 25, 2012
The 2011 ESPEN Arvid Wretlind lecture: cancer cachexia: the potential impact of translational research on patient-focused outcomesK C H Fearon
European Journal of Cancer (Oxford, England : 1990)|April 1, 2008
Cancer cachexia: developing multimodal therapy for a multidimensional problemK C H Fearon
Palliative Medicine|August 31, 2004
Research methodology: cancer cachexia syndromeMax Dahele, K C H Fearon
Bone|August 29, 2015
Emerging therapeutic concepts for muscle and bone preservation/formationJ Compston, K C H Fearon
Surgery|June 11, 2003
Supplemental perioperative fluid administration increases tissue oxygen pressureA L Tambyraja, K C H Fearon
The International Journal of Biochemistry & Cell Biology|June 18, 2013
Muscle wasting in cancerN Johns, N A Stephens, K C H Fearon
Nutrition (Burbank, Los Angeles County, Calif.)|April 27, 2005
Eicosapentaenoic acid modulates the immune response but has no effect on a mimic of antigen-specific responsesM D Barber, K C H Fearon, J A Ross
Annales Francaises D'Anesthesie Et De Reanimation|December 4, 2014
[Enhanced recovery after elective colorectal surgery: reply]D N Lobo, K C H Fearon, M J Scott, et al.
British Journal of Cancer|March 5, 2004
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acidsA W G Moses, C Slater, T Preston, et al.
Gut|January 14, 2005
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resectionM J Schindl, D N Redhead, K C H Fearon, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Clinical Nutrition (Edinburgh, Scotland)|July 25, 2012
The 2011 ESPEN Arvid Wretlind lecture: cancer cachexia: the potential impact of translational research on patient-focused outcomesK C H Fearon
European Journal of Cancer (Oxford, England : 1990)|April 1, 2008
Cancer cachexia: developing multimodal therapy for a multidimensional problemK C H Fearon
Palliative Medicine|August 31, 2004
Research methodology: cancer cachexia syndromeMax Dahele, K C H Fearon
Bone|August 29, 2015
Emerging therapeutic concepts for muscle and bone preservation/formationJ Compston, K C H Fearon
Surgery|June 11, 2003
Supplemental perioperative fluid administration increases tissue oxygen pressureA L Tambyraja, K C H Fearon
The International Journal of Biochemistry & Cell Biology|June 18, 2013
Muscle wasting in cancerN Johns, N A Stephens, K C H Fearon
Nutrition (Burbank, Los Angeles County, Calif.)|April 27, 2005
Eicosapentaenoic acid modulates the immune response but has no effect on a mimic of antigen-specific responsesM D Barber, K C H Fearon, J A Ross
Annales Francaises D'Anesthesie Et De Reanimation|December 4, 2014
[Enhanced recovery after elective colorectal surgery: reply]D N Lobo, K C H Fearon, M J Scott, et al.
British Journal of Cancer|March 5, 2004
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acidsA W G Moses, C Slater, T Preston, et al.
Gut|January 14, 2005
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resectionM J Schindl, D N Redhead, K C H Fearon, et al.
Pageof 5